MED-Ipratropium

Parasympatholytic Bronchodilator

Acts directly on the smooth muscle of the bronchial tree by inhibiting interaction of ACh at receptor sites resulting in bronchodilation.

• Bronchospasm
• Patients with reversible obstructive airway disease

Hypersensitivity to ipratropium, atropine, soya lecithin, peanut oil

Use with caution in pregnancy and lactation

• N/V
• Cramps
• Dry mouth
• Blurred vision
• Worsening bronchospasm
• Drying of bronchial secretions
• Cough
• Epistaxis

None

• Adult: 0.5 mg in 2.5-3 mL NS via nebulizer q 6 hours
• Pedi: 0.125-0.25 mg in 2.5-3 mL NS via nebulizer q 6 hours